SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000936392-04-000210
Filing Date
2004-03-15
Accepted
2004-03-12 21:41:58
Documents
6
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K YEAR ENDED 12-31-03 a97264e10vk.htm 10-K 627181
3 EXHIBIT 10.40 a97264exv10w40.txt EX-10.40 10133
4 EXHIBIT 23.1 a97264exv23w1.txt EX-23.1 1058
5 EXHIBIT 31.1 a97264exv31w1.txt EX-31.1 4102
6 EXHIBIT 31.2 a97264exv31w2.txt EX-31.2 4109
7 EXHIBIT 32.1 a97264exv32w1.txt EX-32.1 1997
  Complete submission text file 0000936392-04-000210.txt   650680
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24274 | Film No.: 04667550
SIC: 2836 Biological Products, (No Diagnostic Substances)